MCID: PLS011
MIFTS: 60

Plasmacytoma

Categories: Rare diseases, Cancer diseases, Neuronal diseases, Blood diseases, Immune diseases

Aliases & Classifications for Plasmacytoma

MalaCards integrated aliases for Plasmacytoma:

Name: Plasmacytoma 12 49 55 51 41 14 69
Solitary Plasmacytoma 12 49 55
Solitary Osseous Plasmacytoma 69
Plasmacytoma - Category 69
Myeloma - Solitary 12
Myeloma, Solitary 12
Solitary Myeloma 12

Characteristics:

Orphanet epidemiological data:

55
plasmacytoma
Inheritance: Not applicable; Age of onset: Adult; Age of death: elderly;

Classifications:



External Ids:

Disease Ontology 12 DOID:3721
ICD10 32 C90.3 C90.30
MeSH 41 D010954
NCIt 46 C6932 C9349
Orphanet 55 ORPHA86855
MESH via Orphanet 42 D010954
UMLS via Orphanet 70 C0032131
ICD10 via Orphanet 33 C90.2 C90.3

Summaries for Plasmacytoma

MalaCards based summary : Plasmacytoma, also known as solitary plasmacytoma, is related to extramedullary plasmacytoma and solitary osseous plasmacytoma, and has symptoms including bone pain An important gene associated with Plasmacytoma is IL6 (Interleukin 6), and among its related pathways/superpathways are Innate Immune System and Cytokine Signaling in Immune system. The drugs Cyclophosphamide and Lenograstim have been mentioned in the context of this disorder. Affiliated tissues include bone, bone marrow and t cells, and related phenotypes are cellular and hematopoietic system

Related Diseases for Plasmacytoma

Diseases related to Plasmacytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 244)
# Related Disease Score Top Affiliating Genes
1 extramedullary plasmacytoma 33.1 B2M IGKC IL2 IL6
2 solitary osseous plasmacytoma 32.7 B2M CD38 NCAM1
3 tonsillitis 30.2 CD79A IL2 IL6
4 cervicitis 30.2 CD79A IL2
5 myeloma, multiple 29.9 B2M CD38 CD79A IL6 IL6R MYC
6 plasma cell neoplasm 29.7 B2M CD38 CD79A IL6 MYC NCAM1
7 castleman disease 29.7 IL6 IL6R
8 plasmablastic lymphoma 29.3 CD38 PTPRC
9 leukemia, chronic lymphocytic 28.5 B2M CD38 IL2 PTPRC
10 combined immunodeficiency, x-linked 28.5 CD38 CD79A IL2 PTPRC
11 extramedullary soft tissue plasmacytoma 12.1
12 anaplastic plasmacytoma 12.1
13 primary plasmacytoma of the bone 12.0
14 solitary plasmacytoma of chest wall 11.9
15 papillary conjunctivitis 10.4 IL11 IL6
16 streptococcal toxic-shock syndrome 10.4 IL2 IL6
17 ovarian lymphoma 10.4 MYC PTPRC
18 immune suppression 10.4 IL2 IL6
19 sclerosing keratitis 10.4 B2M CD79A
20 polyclonal hypergammaglobulinemia 10.4 CD79A IL6
21 orthostatic proteinuria 10.4 B2M CD79A
22 uremic pruritus 10.4 IL2 IL6
23 farmer's lung 10.3 CD79A IL2
24 trichomoniasis 10.3 CD79A IL2
25 diffuse glomerulonephritis 10.2 B2M CD79A
26 thyroiditis 10.2
27 capillary leak syndrome 10.2 IL2 IL6
28 meningoencephalitis 10.2 B2M CD79A IL6
29 lymphoma 10.2
30 danubian endemic familial nephropathy 10.2 B2M CD79A
31 clonorchiasis 10.2 CD79A IL2
32 joint disorders 10.2 IL11 IL6 IL6R
33 urinary system disease 10.2 B2M CD79A IL6
34 endometrial small cell carcinoma 10.2 NCAM1 PTPRC
35 small intestine lymphoma 10.2 B2M CD79A PTPRC
36 chronic kidney failure 10.2 B2M CD79A IL6
37 microscopic colitis 10.2 CD79A IL2 IL6
38 parasitic ichthyosporea infectious disease 10.1 CD79A NCAM1
39 human herpesvirus 8 10.1 IL6 IL6R IL6ST
40 commensal bacterial infectious disease 10.1 CD79A IL2 IL6
41 preterm premature rupture of the membranes 10.1 IL6 IL6R IL6ST
42 rhinosporidiosis 10.1 CD79A NCAM1
43 parasitic protozoa infectious disease 10.1 CD79A IL2 IL6
44 primary bacterial infectious disease 10.1 CD79A IL2 IL6
45 bone inflammation disease 10.1 CD79A IL2 IL6
46 gastric small cell carcinoma 10.1 NCAM1 PTPRC
47 hypersensitivity reaction disease 10.1 CD79A IL2 IL6
48 burning mouth syndrome 10.1 IL2 IL6
49 immune system disease 10.1 CD79A IL2 IL6
50 kaposi sarcoma 10.1 IL6 IL6ST MYC

Graphical network of the top 20 diseases related to Plasmacytoma:



Diseases related to Plasmacytoma

Symptoms & Phenotypes for Plasmacytoma

UMLS symptoms related to Plasmacytoma:


bone pain

MGI Mouse Phenotypes related to Plasmacytoma:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.14 B2M CD38 IL6R CD79A IL6ST EBF1
2 hematopoietic system MP:0005397 10.02 IL6 B2M CD38 IL6R CD79A IL6ST
3 endocrine/exocrine gland MP:0005379 9.97 IL6 B2M CD38 IL6R IL6ST MYC
4 immune system MP:0005387 9.96 IL6 B2M CD38 IL6R CD79A IL6ST
5 liver/biliary system MP:0005370 9.81 IL6R CD79A IL6ST EBF1 MYC IL2
6 neoplasm MP:0002006 9.56 IL6R CD79A IL6ST MYC IL2 IL6
7 nervous system MP:0003631 9.28 IL6 B2M IL6R CD79A IL6ST EBF1

Drugs & Therapeutics for Plasmacytoma

Drugs for Plasmacytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 395)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
2
Lenograstim Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 135968-09-1
3 Thiotepa Approved, Investigational Phase 4,Phase 2,Phase 1 52-24-4 5453
4 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1
5 Antilymphocyte Serum Phase 4,Phase 2,Phase 1
6 Antirheumatic Agents Phase 4,Phase 3,Phase 1,Phase 2
7 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1
8
Bortezomib Approved, Investigational Phase 3,Phase 2,Phase 1 179324-69-7 387447 93860
9
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743
10
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
11
Melphalan Approved Phase 3,Phase 2,Phase 1 148-82-3 460612 4053
12
Carmustine Approved, Investigational Phase 3,Phase 2,Phase 1 154-93-8 2578
13
Methylprednisolone Approved, Vet_approved Phase 3,Phase 2,Phase 1 83-43-2 6741
14
Prednisolone Approved, Vet_approved Phase 3,Phase 2,Phase 1 50-24-8 5755
15
Prednisone Approved, Vet_approved Phase 3,Phase 1,Phase 2 53-03-2 5865
16
Vincristine Approved, Investigational Phase 3,Phase 2,Phase 1 2068-78-2, 57-22-7 5978
17
Idarubicin Approved Phase 3 58957-92-9 42890
18
Lomustine Approved, Investigational Phase 3 13010-47-4 3950
19
Busulfan Approved, Investigational Phase 3,Phase 2,Phase 1 55-98-1 2478
20
Iron Approved Phase 3,Phase 2,Phase 1 7439-89-6 23925
21
Ketamine Approved, Vet_approved Phase 3 6740-88-1 3821
22
Mycophenolate mofetil Approved, Investigational Phase 3,Phase 2,Phase 1 128794-94-5 5281078
23
Mycophenolic acid Approved Phase 3,Phase 2,Phase 1 24280-93-1 446541
24
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 1,Phase 2 22916-47-8 4189
25
Zoledronic acid Approved Phase 3,Phase 1,Phase 2 118072-93-8 68740
26
Pamidronate Approved Phase 3,Phase 2,Phase 1 40391-99-9 4674
27
Lenalidomide Approved Phase 3,Phase 2,Phase 1 191732-72-6 216326
28
Darbepoetin alfa Approved, Investigational Phase 3,Phase 2 209810-58-2, 11096-26-7
29
Ondansetron Approved Phase 3 99614-02-5 4595
30
Dalteparin Approved Phase 3 9005-49-6
31
Heparin Approved, Investigational Phase 3 9005-49-6 46507594 772
32
Dextromethorphan Approved Phase 3 125-71-3 5362449 5360696
33
Guaifenesin Approved, Investigational, Vet_approved Phase 3 93-14-1 3516
34
Morphine Approved, Investigational Phase 3 57-27-2 5288826
35
Amphotericin B Approved, Investigational Phase 3 1397-89-3 5280965 14956
36
deoxycholic acid Approved Phase 3 83-44-3 222528
37
Nystatin Approved, Vet_approved Phase 3 1400-61-9 11953884
38
Ephedrine Approved Phase 3 299-42-3 9294
39
Pseudoephedrine Approved Phase 3 90-82-4 7028
40
Amitriptyline Approved Phase 3 50-48-6 2160
41
Baclofen Approved Phase 3 1134-47-0 2284
42
Perphenazine Approved Phase 3 58-39-9 4748
43
Piperacillin Approved Phase 3 66258-76-2 43672
44
Tazobactam Approved Phase 3 89786-04-9 123630
45
Vancomycin Approved Phase 3 1404-90-6 14969 441141
46
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
47
Caspofungin Approved Phase 3,Phase 2 162808-62-0, 179463-17-3 2826718 468682
48 Ixazomib Approved, Investigational Phase 3,Phase 2 1072833-77-2
49
Daratumumab Approved Phase 3,Phase 2 945721-28-8
50
Estradiol Approved, Investigational, Vet_approved Phase 3 50-28-2 5757

Interventional clinical trials:

(show top 50) (show all 381)

# Name Status NCT ID Phase Drugs
1 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00003398 Phase 4 cyclophosphamide;thiotepa
2 CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma Unknown status NCT02336386 Phase 3 CDD;CDD Plus Bortezomib
3 High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After Chemotherapy Unknown status NCT00747877 Phase 3 cyclophosphamide;melphalan
4 Comparable Investigation of One Fraction Radiotherapy and Multifraction Radiotherapy in Patients With Multiple Myeloma. Unknown status NCT02024815 Phase 3
5 Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma Unknown status NCT00002599 Phase 3 carmustine;cyclophosphamide;doxorubicin hydrochloride;melphalan;methylprednisolone;prednisone;vincristine sulfate
6 Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma Unknown status NCT00014339 Phase 3 Wobe-Mugos E;melphalan;prednisone
7 Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma Unknown status NCT00002653 Phase 3 carmustine;cyclophosphamide;doxorubicin hydrochloride;melphalan;prednisone
8 Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma Unknown status NCT00028886 Phase 3 cyclophosphamide;dexamethasone;doxorubicin hydrochloride;melphalan;thalidomide;vincristine sulfate
9 Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma Unknown status NCT00003603 Phase 3 cyclophosphamide;dexamethasone;idarubicin;lomustine;melphalan;prednisolone
10 Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome Unknown status NCT00002989 Phase 3 busulfan;cyclophosphamide;idarubicin;melphalan
11 Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer Unknown status NCT00482716 Phase 3
12 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3 ketamine hydrochloride
13 Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma Completed NCT00432458 Phase 3 Thalidomide;zoledronic acid
14 Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma Completed NCT00008229 Phase 3 melphalan
15 Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma Completed NCT00002878 Phase 3 dexamethasone;doxorubicin hydrochloride;valspodar;vincristine sulfate
16 Thalidomide and Prednisone After Autologous Stem Cell Transplantation in Treating Patients With Multiple Myeloma Completed NCT00049673 Phase 3 prednisone;thalidomide
17 Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma Completed NCT00033332 Phase 3 dexamethasone;pamidronate disodium;thalidomide;zoledronic acid
18 Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma Completed NCT00017602 Phase 3 dexamethasone
19 Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma Completed NCT00006232 Phase 3 dexamethasone;doxorubicin hydrochloride;idarubicin;vincristine sulfate
20 Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma Completed NCT00004165 Phase 3 melphalan
21 Combination Chemotherapy in Treating Patients With Multiple Myeloma Completed NCT00002678 Phase 3 dexamethasone;melphalan;prednisone
22 Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis Completed NCT00477971 Phase 3 dexamethasone;melphalan
23 S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma Completed NCT00064038 Phase 3 dexamethasone;lenalidomide
24 Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure Completed NCT00416897 Phase 3 chemotherapy;dexamethasone
25 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer Completed NCT00661999 Phase 3 sodium ferric gluconate complex in sucrose
26 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
27 American Ginseng in Treating Patients With Fatigue Caused by Cancer Completed NCT00719563 Phase 3 American ginseng
28 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Completed NCT00666211 Phase 3
29 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3 ondansetron
30 Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Completed NCT00070382 Phase 3 darbepoetin alfa;epoetin alfa
31 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
32 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Completed NCT00006083 Phase 3 Fragmin
33 Treatment for Chronic Pain in Patients With Advanced Cancer Completed NCT00003687 Phase 3 dextromethorphan hydrobromide;morphine sulfate
34 Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy Completed NCT00003341 Phase 3
35 Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) Completed NCT00075829 Phase 3 Thalidomide;Dexamethasone
36 Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer Completed NCT00002742 Phase 3 amphotericin B deoxycholate;nystatin
37 Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer Completed NCT00265837 Phase 3
38 Epoetin Alfa in Treating Anemia in Patients With Solid Tumors Completed NCT00058331 Phase 3
39 Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder Completed NCT00755040 Phase 3 cyclosporine ophthalmic emulsion
40 Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer Completed NCT00516503 Phase 3 baclofen/amitriptyline/ketamine gel
41 Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy Completed NCT00003600 Phase 3
42 Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count Completed NCT00003805 Phase 3 piperacillin sodium;piperacillin-tazobactam;tazobactam sodium;vancomycin
43 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
44 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
45 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
46 Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma Recruiting NCT02544308 Phase 3 Lenalidomide;Dexamethasone
47 Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone Recruiting NCT02516423 Phase 3 ixazomib;lenalidomide;dexamethasone;zoledronic acid
48 Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma Active, not recruiting NCT02136134 Phase 3 Daratumumab;VELCADE (Bortezomib);Dexamethasone
49 Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant Terminated NCT00324324 Phase 3 moxifloxacin hydrochloride;Placebo
50 Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Unknown status NCT00742404 Phase 2 bortezomib;dexamethasone;pegylated liposomal doxorubicin hydrochloride

Search NIH Clinical Center for Plasmacytoma

Cochrane evidence based reviews: plasmacytoma

Genetic Tests for Plasmacytoma

Anatomical Context for Plasmacytoma

MalaCards organs/tissues related to Plasmacytoma:

38
Bone, Bone Marrow, T Cells, Breast, Kidney, Thyroid, Myeloid

Publications for Plasmacytoma

Articles related to Plasmacytoma:

(show top 50) (show all 1071)
# Title Authors Year
1
Extramedullary plasmacytoma: rare neoplasm of parotid gland. ( 29301803 )
2018
2
Extramedullary plasmacytoma of the testis: A case report. ( 29204364 )
2018
3
Testicular plasmacytoma: unique location or circumstantial presentation? ( 29316841 )
2018
4
Collet-Sicard Syndrome Attributable to Extramedullary Plasmacytoma of the Jugular Foramen. ( 29191538 )
2018
5
Anaplastic plasmacytoma: a rare tumor presenting as a pathological fracture in a younger adult. ( 29388036 )
2018
6
Pattern of care and impact of prognostic factors on the outcome of head and neck extramedullary plasmacytoma: a systematic review and individual patient data analysis of 315 cases. ( 29224044 )
2018
7
Skull base plasmacytoma: A unique case of POEMS syndrome with a plasmacytoma causing craniocervical instability. ( 29100675 )
2018
8
Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel. ( 29338789 )
2018
9
Sellar plasmacytoma presenting with symptoms of anterior pituitary dysfunction. ( 29204279 )
2017
10
Endoscopic ultrasound-guided fine needle aspiration and diagnosis of omental plasmacytoma. ( 28663527 )
2017
11
Marginal zone B-cell lymphoma mimicking extramedullary plasmacytoma and the clinical outcome after treatment. ( 28507591 )
2017
12
Rare Presentation of Primary Extramedullary Plasmacytoma as Lip Lesion. ( 28409043 )
2017
13
Uterine Extramedullary Plasmacytoma as a Primary Manifestation of Multiple Myeloma. ( 28834996 )
2017
14
Cerebral Venous Thrombosis with Papilloedema Secondary to Skull Base Plasmacytoma. ( 29339964 )
2017
15
Extramedullary plasmacytoma occuring in ileocecum: A case report and literature review. ( 29390503 )
2017
16
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue with plasma cell differentiation: Periodic acid-schiff reaction-positive Dutcher body is a diagnostic clue to distinguish it from plasmacytoma. ( 28233949 )
2017
17
Extramedullary Plasmacytoma Arising From the Anterior Mediastinum. ( 28431708 )
2017
18
An Extremely Rare Manifestation of Multiple Myeloma: An Immunoglobulin D Secreting Testicular Plasmacytoma. ( 28845377 )
2017
19
Primary pancreatic plasmacytoma: a rare case report. ( 29262780 )
2017
20
Composite Nasopharyngeal plasmacytoma with nodal paraimmunoblastic variant of small lymphocytic lymphoma: A case report. ( 28789404 )
2017
21
Solitary Plasmacytoma. ( 28894561 )
2017
22
Multiple Extramedullary Plasmacytoma in a Setting of Complete Bone Marrow Remission: Food for Thought. ( 29340123 )
2017
23
A case of primary plasma cell leukemia exhibiting hemophagocytic plasma cells relapsed with multiple cutaneous plasmacytoma. ( 29333413 )
2017
24
C2 Solitary Bone Plasmacytoma Curettage and Vertebral Augmentation in an 83-Year-Old Female: Case Report and Review of Surgical Treatment Approaches in the Spine. ( 29391960 )
2017
25
Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register. ( 28544116 )
2017
26
Extramedullary plasmacytoma in the airway of an HIV-positive child. ( 28834349 )
2017
27
Primary extraosseous plasmacytoma of the parotid gland: A case report and literature review. ( 29181165 )
2017
28
Extramedullary sarcomatoid variant of plasmablastic plasmacytoma. ( 29237987 )
2017
29
Primary solitary plasmacytoma of the liver - successful treatment with fractionated stereotactic radiotherapy (CyberknifeAr): a case report. ( 28716071 )
2017
30
Solitary Extramedullary Plasmacytoma of the Cricoid Cartilage-Case Report. ( 29230383 )
2017
31
Complex interventional iliocaval recanalization due to plasmacytoma and cystic echinococcosis. ( 28613113 )
2017
32
A rare case of Epstein-Barr virus-related plasmacytoma involving maxillary sinus mucosa. ( 28878909 )
2017
33
Plasmacytoma of the clivus. ( 28761547 )
2017
34
Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21(st) century. ( 28280077 )
2017
35
An immunocompetent patient with a recurrence-free Epstein-Barr virus positive plasmacytoma possesses robust Epstein-Barr virus specific T-cell responses. ( 28705903 )
2017
36
Strategy for the treatment and follow-up of sinonasal solitary extramedullary plasmacytoma: a case series. ( 28793931 )
2017
37
Extramedullary plasmacytoma mimicking pancreatic cancer: A case report and literature review. ( 28663530 )
2017
38
Extramedullary plasmacytoma of the lateral rectus muscle. ( 28267386 )
2017
39
Epibulbar Plasmacytoma Masquerading as Subconjunctival Hemorrhage in a Patient With Multiple Myeloma. ( 28060076 )
2017
40
Bilateral extramedullary adrenal plasmacytoma: case report and review of the literature. ( 28758008 )
2017
41
Cutaneous Plasmacytoma: Metastasis of Multiple Myeloma at the Fracture Site. ( 28761299 )
2017
42
Desmin-positive anaplastic plasmacytoma involving the nasopharynx. ( 28168725 )
2017
43
Progression of cutaneous plasmacytoma to plasma cell leukemia in a dog. ( 28186653 )
2017
44
Management of extramedullary plasmacytoma: Role of radiotherapy and prognostic factor analysis in 55 patients. ( 29142463 )
2017
45
Relapsed Multiple Myeloma Presenting as Intracranial Plasmacytoma and Malignant Pericardial Effusion following Recent Allogeneic Stem Cell Transplantation. ( 28868016 )
2017
46
Multiple Myeloma Presenting as Thyroid Plasmacytoma. ( 29333030 )
2017
47
An extramedullary plasmacytoma in the kidney of a 14-year-old girl: Case report and review of the literature. ( 28178171 )
2017
48
18F-FDG PET/CT in solitary plasmacytoma: metabolic behavior and progression to multiple myeloma. ( 28822997 )
2017
49
Solitary Osteogenic Sternum Plasmacytoma on Bone Scintigraphy and FDG PET/CT. ( 28902727 )
2017
50
Extramedullary plasmacytoma of the testicle. ( 29205163 )
2017

Variations for Plasmacytoma

Expression for Plasmacytoma

Search GEO for disease gene expression data for Plasmacytoma.

Pathways for Plasmacytoma

Pathways related to Plasmacytoma according to GeneCards Suite gene sharing:

(show all 30)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.89 B2M CD79A IL11 IL2 IL6 IL6R
2
Show member pathways
13.15 B2M IL11 IL2 IL6 IL6R IL6ST
3 12.7 IL2 IL6 IL6R IL6ST MYC
4
Show member pathways
12.5 CD79A IGKC IL2 PTPRC
5
Show member pathways
12.47 IL2 IL6 IL6R IL6ST MYC
6
Show member pathways
12.11 IL11 IL2 IL6 IL6R IL6ST MYC
7 12.01 B2M CD38 CD79A IL2 IL6ST NCAM1
8
Show member pathways
11.99 IL6 IL6R IL6ST
9 11.95 IL11 IL6 MYC NCAM1
10 11.93 EBF1 IL6 IL6ST
11 11.89 IL2 IL6 MYC
12 11.86 IL6 IL6R MYC
13 11.82 IL6 IL6R IL6ST
14
Show member pathways
11.81 IL2 IL6 IL6ST
15
Show member pathways
11.76 IL6 IL6R IL6ST
16 11.76 CD38 IL11 IL6 IL6R
17
Show member pathways
11.74 IL6 IL6R IL6ST
18 11.74 CD79A IL6 NCAM1 PTPRC
19 11.67 IL2 NCAM1 PTPRC
20
Show member pathways
11.64 IL6 IL6R IL6ST MYC
21 11.63 IL2 IL6 IL6R IL6ST PTPRC
22 11.48 CD38 IL6R PTPRC
23 11.45 IL6 IL6R MYC
24
Show member pathways
11.43 IL11 IL6 IL6R IL6ST
25 11.42 IL11 IL6 IL6R
26 11.42 CD38 IL2 IL6 NCAM1 PTPRC
27
Show member pathways
11.35 IL6 IL6R IL6ST
28 11.23 CD38 CD79A IL11 IL2 IL6 NCAM1
29 11.2 IL6 IL6R IL6ST
30 11.15 IL11 IL2 IL6

GO Terms for Plasmacytoma

Cellular components related to Plasmacytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.91 B2M CNTN3 IGKC IL11 IL2 IL6
2 external side of plasma membrane GO:0009897 9.43 B2M CD79A IGKC IL6ST NCAM1 PTPRC
3 ciliary neurotrophic factor receptor complex GO:0070110 9.16 IL6R IL6ST
4 interleukin-6 receptor complex GO:0005896 8.8 IL6 IL6R IL6ST

Biological processes related to Plasmacytoma according to GeneCards Suite gene sharing:

(show all 19)
# Name GO ID Score Top Affiliating Genes
1 negative regulation of apoptotic process GO:0043066 9.91 CD38 IL2 IL6 IL6ST MYC
2 positive regulation of cell proliferation GO:0008284 9.8 IL11 IL2 IL6 IL6R IL6ST MYC
3 cytokine-mediated signaling pathway GO:0019221 9.76 IL6 IL6R IL6ST
4 positive regulation of peptidyl-tyrosine phosphorylation GO:0050731 9.7 IL11 IL6 IL6R
5 response to cytokine GO:0034097 9.67 CD38 IL6R IL6ST
6 positive regulation of smooth muscle cell proliferation GO:0048661 9.65 IL6 IL6R MYC
7 positive regulation of osteoblast differentiation GO:0045669 9.63 IL6 IL6R IL6ST
8 positive regulation of chemokine production GO:0032722 9.58 IL6 IL6R
9 positive regulation of B cell proliferation GO:0030890 9.58 CD38 IL2 PTPRC
10 positive regulation of leukocyte chemotaxis GO:0002690 9.57 IL6 IL6R
11 negative regulation of bone resorption GO:0045779 9.56 CD38 IL6
12 B cell receptor signaling pathway GO:0050853 9.56 CD38 CD79A IGKC PTPRC
13 positive regulation of acute inflammatory response GO:0002675 9.55 IL6 IL6ST
14 positive regulation of immunoglobulin secretion GO:0051024 9.54 IL2 IL6
15 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.46 IL2 IL6 IL6R IL6ST
16 ciliary neurotrophic factor-mediated signaling pathway GO:0070120 9.43 IL6R IL6ST
17 hepatic immune response GO:0002384 9.37 IL6 IL6R
18 positive regulation of T cell proliferation GO:0042102 9.26 IL2 IL6 IL6ST PTPRC
19 interleukin-6-mediated signaling pathway GO:0070102 8.8 IL6 IL6R IL6ST

Molecular functions related to Plasmacytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 ciliary neurotrophic factor receptor activity GO:0004897 9.26 IL6R IL6ST
2 interleukin-6 binding GO:0019981 9.16 IL6R IL6ST
3 interleukin-6 receptor activity GO:0004915 8.96 IL6R IL6ST
4 interleukin-6 receptor binding GO:0005138 8.8 IL6 IL6R IL6ST

Sources for Plasmacytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....